ANGOAngioDynamics, Inc.
$11.22+1.5% 1Y
$11.22
$9.7052 weeks$16.12
Latest close: below its 200-day averageOct 8, 2026what changed →
The financials
AngioDynamics, Inc. by the numbers
AngioDynamics, Inc. (ANGO) reported revenue of $81M in Q1 2027 (quarter ended Aug 31, 2026), up 6.9% from the same quarter a year earlier. That came with a gross margin of 59% and net loss of $7.1M. For the full year FY2026, revenue was $320M (+9.5% year on year) and net income −$37M. The next results filing is expected around Jan 5, 2027, the same week as a year ago.
| Income statement | Q1 2027 | Q1 2026 | Change |
|---|---|---|---|
| Revenue | $81M | $76M | +6.9% |
| Gross profit | $48M | $42M | +15% |
| Operating income | −$7.3M | −$11M | n/a |
| Net income | −$7.1M | −$11M | n/a |
| Diluted EPS | −$0.17 | −$0.26 | n/a |
Medical Instruments & Supplies
Ranks #20 of 21 by RyuScore